Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Prote

Abstract:
Sunshine Bio Investments World, a privately held Canadian company (www.sunshinebioworld.com), has established U.S. headquarters in Miami and initiated venture funding for a variety of biotech, pharmaceutical and medical device companies active in the multi-billion dollar North American biotech environment.

Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Prote

Miami, FL | Posted on November 20th, 2008

Miami operations are located at 5600 Collins Avenue, Suite 17C, Miami, Florida, 33140. Telephone is 305-433-2121.

According to Michael Di Turi, Sunshine Bio Investments World President and CEO, "Most investment banks in the North American markets do not closely follow small and mid-cap biotech and biodefense sectors. At the same time, many analysts are not adequately qualified to fairly and thoroughly evaluate the potential of these companies.

"Pharmagenomics, nanomedicine and regenerative medicine will predict, prevent and cure life-threatening viruses and diseases," continued Mr. Di Turi. "Sunshine Bio Investments World partners are at the forefront of 21st century technologies. We are seeking partners and alliances to develop, market and distribute products and solutions to improve the health, safety and security of individuals worldwide," he said.

Sunshine Bio Investments World Companies Are Already Making Breakthroughs, Contributing to Respective Industries

Mr. Di Turi added, "Companies we are presently funding are located across Canada, California and Florida, contributing to industry knowledge, and making significant scientific breakthroughs. Areas of expertise include commercialization of drug-based therapies to treat central nervous system diseases, programs to repair neurological function lost due to disease or injury, single-walled carbon nanotubes, nanomaterials and other advanced materials for high value-added applications; and clinically proven procedures available for the cryogenic storage of umbilical cord blood (UCB)."

####

For more information, please click here

Contacts:
Tony Sciangula
Sunshine Bio Investments World
786-704-4509

or
Steven Swartz
SIZZLE PR
978-524-9595

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Superfast light source made from artificial atom April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Save the Date: D-Wave Systems, HZO and Metabolon to Present at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center February 16th, 2016

Openings/New facilities/Groundbreaking/Expansion

SUNY Poly Partnership with Japan's New Energy and Industrial Development Organization Drives Investment in and Installation of Emerging ‘Green’ Technologies at World-Class 'Zero Energy Nano' Building March 22nd, 2016

Investments/IPO's/Splits

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Arrowhead to Present at Upcoming March Conferences March 1st, 2016

Announcements

Superfast light source made from artificial atom April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic